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The Editorial on the Research Topic
Global Health and Medical Travel
Travel for medical care is increasing globally. This ranges from patients with urgent medical needs 
who must travel abroad for specialist care, to medical tourists who elect to have certain procedures 
abroad. While estimated increases of patients traveling abroad for medical care vary, more empiri-
cal research and evidence is needed to understand the scale, reasons, and consequences of travel. 
The preceding Research Topic has been compiled to reflect significant gaps in evidence and policy 
specifically for medical travel, referring here to care that is essential to maintain quality of life, largely 
influenced by the Global Health Access Policy (GHAP) project, which was carried out from 2012 
to 2015.
The editors had previously called for more scientific evidence to support the development of 
such policies and more nuanced definitions rather than interchangeable use of “medical tourism” 
and “medical travel” (1). We noted that, prior to the GHAP project, research on medical travel had 
generally been limited to medical tourism or simplified exchanges between few locations over a 
limited scope of care. Studies lacked extensive review required to inform medical travel policies for 
those with urgent needs and did not consider factors such as patient protection and indemnification, 
psychological support during rehabilitation, and long-term liability (2). For this reason, this Topic 
was convened to invite studies that contribute evidence toward the development of such policies 
specific to medical travel, which emphasizes more critical care than much of the work on medical 
tourism. The following is a summary of arguments made therein.
iNtErNatioNal QUalitY StaNdardS
Myriad treatments may prompt medical travel, each of which have different pricing implications 
and address a variety of needs. Judgment on whether to include specific treatment policies requires 
direct quality assessment of those treatments. Existing international standards, such as the OECD 
Health Care Quality Indicators, are more conceptual and therefore lack the detail necessary to ensure 
specific procedural standards. The Perspective by Kácha et al.  suggests the domains included in such 
a framework for international quality standards should include minimum quality standards globally, 
financial responsibility for all prior to and following care, patient centeredness, and consideration 
of local cultural challenges. They suggest prioritizing more specific standards by procedure and 
establishing comparable safety and quality indicators.
PatiENt CHoiCE aNd MEdiCal traVEl
When treatment is unavailable (e.g., not offered locally, excessive waiting list) or particularly difficult 
to access (e.g., high cost, poor quality), medical travel is an increasingly common option. Though 
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studies have identified factors in decision-making processes 
regarding medical travel, it is not clear which have the greatest 
influence and how they may interact to influence outcomes. 
Such insights are necessary to understand choice. The article 
by Zhukovsky et al. surveying patient choice among a predomi-
nantly well-educated, European sample showed that individuals 
display high willingness to travel for medical care. They also 
found that cost was less important than quality and waiting time 
for treatment. As the authors note, if treated carefully, insights 
into influences on patient choice could be valuable in establish-
ing relevant, population-appropriate policies. Further research 
must identify locations involved and how these affect reasons for 
traveling among larger samples, especially for future insight into 
specific treatments.
lEGal FraMEWorKS
Increased medical travel may result in uncontrolled movement 
of patients. This carries significant risks for both patients and 
health-care systems with respect to quality standards, spread of 
disease, financial implications of adverse events, and unregu-
lated health-care markets (3, 4). Globally, however, medical 
travel remains a widely unregulated extension of health care. 
In one Perspective, we seek to address existing gaps in the 
regulation of medical travel by identifying the requirements for 
an economic and legal considerations framework for medical 
travel. These are based on a non-systematic, targeted literature 
review. Legal considerations include the standardizations of visa 
procedures, implementation of international quality standards, 
accreditation of health-care providers, and third-party agencies, 
and the protection of the local population, and the monitoring 
of information provided to patients to ensure informed decision 
making. Economic considerations include a dynamic approach 
to pricing that is fair to the local population. This list is not 
definitive, and we welcome further empirical research from 
economic and legal perspectives to utilize and build upon this 
framework.
WEll-BEiNG
We were pleased to include a review highlighting the importance 
of seeing medical travel’s potential value beyond treatment. In 
the work by Záliš et al. a clear argument is presented for ensuring 
that the ultimate outcome of interest must be the wider impact 
on well-being, not simply volumes of patients receiving care. This 
is critical as it speaks directly to the trade-off policymakers must 
make between access and outcomes. Instances where faster or 
lower-cost care abroad creates risks to well-being that outweigh 
the gains are rightly outlined. We would hope this piece spurs 
debate and discussion regarding the topics it raises and their 
wider implications.
FUtUrE CoNSidEratioNS
While access to care is clearly a positive incentive for travel, it is 
not without risks, even beyond the clinic. Well-being literature 
(5, 6) highlights the importance of social support in recovery 
and the idea of traveling abroad for care would seem to ignore 
this. Therefore, wider impacts on well-being should build on the 
evidence generated, as will those employer insurance plans that 
include medical travel.
The themes of this Research Topic are not exhaustive but 
rather serve to lay foundations for evidence required in future 
developments for medical travel policy. For research to be effec-
tive, evidence will have to be gathered with consideration of all 
the above elements, as well as potential gains or opportunities to 
improve access, quality of care, and health equity. There are also 
wider considerations that span beyond health services, includ-
ing the development of pricing structures, engagement with 
third parties (e.g., visa services, travel industry), and stratified 
evidence based on treatments, regions, and clinicians, among 
many. Ultimately, it is clear that the challenge of medical travel 
is not only cross-national, but cross-sectoral: research should 
generate information for patients, clinicians, industry, and 
policymakers alike. Only then can the economic and medical 
benefits be responsibly explored through wider medical travel 
programs.
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